The team of Lian et al. (2018a) demonstrated that DUXAP10 expression was higher in renal cell carcinoma patients with an advanced TNM stage and positive lymph node metastasis. This evidence concerns the gene DUXAP10 and hereditary clear cell renal cell carcinoma.